human dose for dihexa (PNB-0408) — Dosing, Side Effects, FDA Status & Research | PeptIQ DIHEXA

It never made it through full clinical trials in humans

Follow-up analyses using exploratory factor analysis reinforced the predominant association between shorter sleep/insufficiency and TSPO levels in the MFC, but not between longer sleep and TSPO levels in the hippocampus and putamen

For laboratories focused on oral peptide pharmacology, these capsules eliminate the reconstitution step and associated sterility concerns inherent in working with lyophilized powders

BPC-157 protects somatosensory neurons, promotes peripheral nerve regeneration after transection, counteracts the otherwise progressing course after traumatic brain injury, and in rat spinal cord compression models with tail paralysis, addresses axonal and neuronal necrosis, demyelination, and cyst formation while rescuing tail function